Jefferies Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-19,865
| Closed | -$1.69M | – | 1205 |
|
2021
Q4 | $1.69M | Sell |
19,865
-6,942
| -26% | -$591K | 0.01% | 468 |
|
2021
Q3 | $2.57M | Sell |
26,807
-14,736
| -35% | -$1.41M | 0.02% | 353 |
|
2021
Q2 | $4.04M | Buy |
41,543
+6,483
| +18% | +$631K | 0.03% | 304 |
|
2021
Q1 | $3.41M | Buy |
35,060
+35,001
| +59,324% | +$3.4M | 0.03% | 284 |
|
2020
Q4 | $5.66K | Sell |
59
-34,518
| -100% | -$3.31M | ﹤0.01% | 971 |
|
2020
Q3 | $3.33M | Buy |
34,577
+27,327
| +377% | +$2.63M | 0.04% | 202 |
|
2020
Q2 | $885 | Sell |
7,250
-27,796
| -79% | -$3.39K | 0.01% | 452 |
|
2020
Q1 | $3.03M | Sell |
35,046
-16,233
| -32% | -$1.4M | 0.03% | 236 |
|
2019
Q4 | $5.51M | Sell |
51,279
-93,066
| -64% | -$10M | 0.04% | 216 |
|
2019
Q3 | $13M | Buy |
144,345
+74,173
| +106% | +$6.68M | 0.1% | 39 |
|
2019
Q2 | $5.93M | Buy |
70,172
+67,615
| +2,644% | +$5.71M | 0.04% | 135 |
|
2019
Q1 | $225K | Sell |
2,557
-53,689
| -95% | -$4.72M | ﹤0.01% | 1195 |
|
2018
Q4 | $4.02M | Buy |
56,246
+3,123
| +6% | +$223K | 0.03% | 218 |
|
2018
Q3 | $6.53M | Sell |
53,123
-17,755
| -25% | -$2.18M | 0.04% | 162 |
|
2018
Q2 | $6.96M | Buy |
70,878
+65,878
| +1,318% | +$6.47M | 0.04% | 148 |
|
2018
Q1 | $415K | Sell |
5,000
-1,868
| -27% | -$155K | ﹤0.01% | 980 |
|
2017
Q4 | $533K | Buy |
6,868
+3,519
| +105% | +$273K | ﹤0.01% | 1036 |
|
2017
Q3 | $205K | Buy |
+3,349
| New | +$205K | ﹤0.01% | 1341 |
|
2017
Q1 | – | Sell |
-9,216
| Closed | -$357K | – | 1619 |
|
2016
Q4 | $357K | Sell |
9,216
-4,494
| -33% | -$174K | ﹤0.01% | 932 |
|
2016
Q3 | $694K | Buy |
13,710
+6,707
| +96% | +$340K | ﹤0.01% | 713 |
|
2016
Q2 | $318K | Buy |
+7,003
| New | +$318K | ﹤0.01% | 850 |
|
2016
Q1 | – | Hold |
0
| – | – | – | 1458 |
|
2015
Q4 | – | Hold |
0
| – | – | – | 1436 |
|
2014
Q1 | – | Sell |
-12,396
| Closed | -$116K | – | 1452 |
|
2013
Q4 | $116K | Buy |
12,396
+12,200
| +6,224% | +$114K | ﹤0.01% | 1071 |
|
2013
Q3 | $2K | Sell |
196
-312
| -61% | -$3.18K | ﹤0.01% | 1192 |
|
2013
Q2 | $7K | Buy |
+508
| New | +$7K | ﹤0.01% | 1133 |
|